Healthcare AI Acquisition Corp. (HAIAU) Stock

About Healthcare AI Acquisition Corp.

Healthcare AI Acquisition Corp. currently lacks substantial business activities. Its core mission is to execute a business combination, such as a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more suitable companies or entities. The firm specifically intends to focus on businesses within the healthcare and pharmaceutical industries, particularly those involved in e-clinical services, healthcare information technology, or outsourced pharmaceutical services. Established in 2021, the company's base of operations is in George Town, Cayman Islands.

Healthcare AI Acquisition Corp. is headquartered in KY.

Healthcare AI Acquisition Corp. (HAIAU) stock trades at $11.50 with a market capitalization of $63.75M. The stock is valued at a negative price-to-earnings (P/E) ratio of -108.39, reflecting a net loss over the last twelve months, a negative price-to-book of -29.93, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $11.50 and $11.50, and currently trades at or near its 52-week high.

On profitability, Healthcare AI Acquisition Corp. generates a return on equity (ROE) of -120.29% (negative, reflecting a net loss), return on capital employed of -21.25%.